Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1950 1
1951 3
1952 1
1953 3
1954 3
1955 1
1966 3
1967 1
1968 2
1969 3
1971 1
1972 2
1973 1
1974 1
1975 1
1976 2
1978 2
1979 1
1980 1
1981 2
1985 1
1986 1
1987 2
1989 2
1990 3
1991 3
1992 2
1993 4
1994 4
1995 4
1996 12
1997 8
1998 6
1999 9
2000 5
2001 4
2002 8
2003 6
2004 7
2005 7
2006 7
2007 14
2008 8
2009 4
2010 11
2011 10
2012 11
2013 12
2014 12
2015 15
2016 23
2017 9
2018 16
2019 19
2020 18
2021 15
2022 14
2023 19
2024 14
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

349 results

Results by year

Filters applied: . Clear all
Page 1
Obesity I: Overview and molecular and biochemical mechanisms.
Lustig RH, Collier D, Kassotis C, Roepke TA, Kim MJ, Blanc E, Barouki R, Bansal A, Cave MC, Chatterjee S, Choudhury M, Gilbertson M, Lagadic-Gossmann D, Howard S, Lind L, Tomlinson CR, Vondracek J, Heindel JJ. Lustig RH, et al. Among authors: cave mc. Biochem Pharmacol. 2022 May;199:115012. doi: 10.1016/j.bcp.2022.115012. Epub 2022 Apr 5. Biochem Pharmacol. 2022. PMID: 35393120 Free PMC article. Review.
Obesity II: Establishing causal links between chemical exposures and obesity.
Heindel JJ, Howard S, Agay-Shay K, Arrebola JP, Audouze K, Babin PJ, Barouki R, Bansal A, Blanc E, Cave MC, Chatterjee S, Chevalier N, Choudhury M, Collier D, Connolly L, Coumoul X, Garruti G, Gilbertson M, Hoepner LA, Holloway AC, Howell G 3rd, Kassotis CD, Kay MK, Kim MJ, Lagadic-Gossmann D, Langouet S, Legrand A, Li Z, Le Mentec H, Lind L, Monica Lind P, Lustig RH, Martin-Chouly C, Munic Kos V, Podechard N, Roepke TA, Sargis RM, Starling A, Tomlinson CR, Touma C, Vondracek J, Vom Saal F, Blumberg B. Heindel JJ, et al. Among authors: cave mc. Biochem Pharmacol. 2022 May;199:115015. doi: 10.1016/j.bcp.2022.115015. Epub 2022 Apr 5. Biochem Pharmacol. 2022. PMID: 35395240 Free PMC article. Review.
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
Toxicant-associated steatohepatitis.
Wahlang B, Beier JI, Clair HB, Bellis-Jones HJ, Falkner KC, McClain CJ, Cave MC. Wahlang B, et al. Among authors: cave mc. Toxicol Pathol. 2013 Feb;41(2):343-60. doi: 10.1177/0192623312468517. Epub 2012 Dec 21. Toxicol Pathol. 2013. PMID: 23262638 Free PMC article. Review.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.
Gawrieh S, Dasarathy S, Tu W, Kamath PS, Chalasani NP, McClain CJ, Bataller R, Szabo G, Tang Q, Radaeva S, Barton B, Nagy LE, Shah VH, Sanyal AJ, Mitchell MC; AlcHepNet Investigators. Gawrieh S, et al. J Hepatol. 2024 May;80(5):684-693. doi: 10.1016/j.jhep.2024.01.031. Epub 2024 Feb 10. J Hepatol. 2024. PMID: 38342441 Free PMC article. Clinical Trial.
Metabolism disrupting chemicals and metabolic disorders.
Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, Nadal A, Palanza P, Panzica G, Sargis R, Vandenberg LN, Vom Saal F. Heindel JJ, et al. Among authors: cave m. Reprod Toxicol. 2017 Mar;68:3-33. doi: 10.1016/j.reprotox.2016.10.001. Epub 2016 Oct 17. Reprod Toxicol. 2017. PMID: 27760374 Free PMC article. Review.
Changes in m6A in Steatotic Liver Disease.
Petri BJ, Cave MC, Klinge CM. Petri BJ, et al. Among authors: cave mc. Genes (Basel). 2023 Aug 19;14(8):1653. doi: 10.3390/genes14081653. Genes (Basel). 2023. PMID: 37628704 Free PMC article. Review.
Viral antibody response predicts morbidity and mortality in alcohol-associated hepatitis.
Hsu CL, Wang L, Maestri E, Jacob AR, Do WL, Mayo S, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross DL, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Stärkel P, Bataller R, Investigators A, Wang XW, Schnabl B. Hsu CL, et al. Hepatology. 2025 Jul 1;82(1):127-139. doi: 10.1097/HEP.0000000000001046. Epub 2024 Sep 25. Hepatology. 2025. PMID: 39325984
Liver diseases.
Obert J, Cave M, Marsano L. Obert J, et al. Among authors: cave m. World Rev Nutr Diet. 2015;111:146-50. doi: 10.1159/000362314. Epub 2014 Nov 17. World Rev Nutr Diet. 2015. PMID: 25418405 No abstract available.
349 results